000220.KS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 09:30):

Stats
Dzisiejszy wolumen	37 171.00
Średni wolumen	154 849
Kapitalizacja rynkowa	76.38B
EPS	KRW0 ( 2023-09-30 )
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW6.14 (0.13%)

Wolumen Korelacja

Długi: 0.06 (neutral)

Krótki: -0.88 (strong negative)

Signal:(60.358) Neutral

Yuyu Pharma, Inc. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Yuyu Pharma, Inc. Korelacja - Waluta/Towar

-0.72
( moderate negative )

-0.68
( moderate negative )

-0.70
( moderate negative )

-0.66
( moderate negative )

-0.14
( neutral )

0.65
( weak )

Yuyu Pharma, Inc. Finanse

Annual	2023
Przychody:	KRW137.21B
Zysk brutto:	KRW46.51B (33.89 %)
EPS:	KRW-441.41

FY	2023
Przychody:	KRW137.21B
Zysk brutto:	KRW46.51B (33.89 %)
EPS:	KRW-441.41

FY	2022
Przychody:	KRW138.88B
Zysk brutto:	KRW53.31B (38.39 %)
EPS:	KRW-266.90

FY	2021
Przychody:	KRW115.66B
Zysk brutto:	KRW45.34B (39.20 %)
EPS:	KRW-21.10

Financial Reports:

No articles found.

Yuyu Pharma, Inc.

Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, including osteoporosis, brainbone metabolism-hypocalcemia improvement, cerebral and peripheral circulatory disturbance, tromboembolism, respiratory organ, hypertension, pulmonary tuberculosis therapy, arthrifuge, diabetic neuropathy therapy, eczematous dermatitis drugs, and other circulatory system drugs, as well as antibiotics and skeletal muscle relaxants. It also provides non-prescription drugs and health supplements. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Seoul, South Korea.